A novel 12-biomarker serum test was developed to quantify rheumatoid arthritis disease activity.
We followed a stepwise approach to develop a quantitative serum-based measure of RA disease activity, based on 12-biomarkers, which was consistently associated with clinical disease activity levels.
No takes yet. Share an insight, caveat, or question.
Centola et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: